Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies
Top Cited Papers
Open Access
- 8 November 2014
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 148 (3), 553-561
- https://doi.org/10.1007/s10549-014-3144-y
Abstract
The online version of this article (doi:10.1007/s10549-014-3144-y) contains supplementary material, which is available to authorized users.Keywords
This publication has 19 references indexed in Scilit:
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicityBreast Cancer Research and Treatment, 2012
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyThe Lancet, 2011
- Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trialsBritish Journal of Cancer, 2010
- Triple-negative breast cancer—current status and future directionsAnnals of Oncology, 2009
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast CancerClinical Breast Cancer, 2009
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTCAnnals of Oncology, 1996
- Corrected group prognostic curves and summary statisticsJournal of Chronic Diseases, 1982
- Adjusted survival curve estimation using covariatesJournal of Chronic Diseases, 1982